Results 261 to 270 of about 3,008,012 (393)

WHO malaria nucleic acid amplification test external quality assessment scheme: results of eleven distributions over 6 years. [PDF]

Malar J
Thomson RM, Cunningham JA, Gatton MM, Murphy SC, de la Paz Ade M, Ding XC, Incardona S, Legrand E, Lucchi N, Menard D, Nsobya SL, Saez AC, Shrivastava J, Chiodini PL.   +13 more
europepmc   +1 more source

An International External Quality Assessment Scheme to Assess the Diagnostic Performance of Polymerase Chain Reaction Detection of Acanthamoeba Keratitis. [PDF]

Cornea, 2023
Sarink MJ, Koelewijn R, Stelma F, Kortbeek T, van Lieshout L, Smit PW, Tielens AGM, van Hellemond JJ.   +7 more
europepmc   +1 more source

Expanding Hereditary Spastic Paraplegias Limits: Biallelic SPAST Variants in Cerebral Palsy Mimics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Hereditary spastic paraplegias (HSP) are rare neurodegenerative disorders marked by spasticity and lower limb weakness. The most common type, SPG4, is usually autosomal dominant and caused by SPAST gene variants, typically presenting as pure HSP.
Gregorio A. Nolasco, Mònica Roldán, Yalda Jamshidi, Ioannis Georvasilis, Rocío Jadraque Rodríguez, Reza Boostani, Ali Shoeibi, Lluís Armengol, Anna Codina, Ehsan Ghayoor Karimiani, Cristina Hernando‐Davalillo, Loreto Martorell, María Luisa Ramírez Almaraz, Jordi Muchart, Carlos Ortez, Andrés Nascimento, Roser Urreizti, Daniel Natera‐de Benito, Mercedes Serrano   +18 more
wiley   +1 more source

Use of external quality assessment in extra-analytical phases in clinical laboratories in Spain: a survey by the Spanish Society of Laboratory Medicine (SEQC^ML). [PDF]

Adv Lab Med
Caballero Garralda A, Reixach IC, García Miralles C, Gómez Rioja R, Llopis Díaz MA, Martínez Espartosa D, Nicolás de Blas R, Panadès Turró M, Puigví Fernández L, Rodelgo Jiménez L, Sufrate-Vergara B, Ventura Orriols E.   +11 more
europepmc   +1 more source

Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019-2020. [PDF]

Influenza Other Respir Viruses, 2023
Williams T, Jackson S, Barr I, Bi S, Bhiman J, Ellis J, von Gottberg A, Lindstrom S, Peret T, Rughooputh S, Viegas M, Hirve S, Zambon M, Zhang W, WHO RSV Surveillance Group, Dia N, Razanazatovo N, Al-Nabet ADMH, Abubakar A, Tivane A, Barakat A, Naguib A, Aziz A, Vicari A, Moen A, Govindakarnavar A, Hall A, Darmaa B, Nathalie B, Herring B, Caetano BC, Whittaker B, Baumeister E, Nakouné E, Guthrie E, Inbanathan F, Nair H, Campbell H, Kadjo HA, Oumzil H, Heraud JM, Mott JA, Namulondo J, Leite J, Nahapetyan K, Al Ariqi L, Gazo MHI, Chadha M, Pisareva M, Venter M, Siqueira MM, Lumandas M, Niang M, Albuaini M, Salman M, Oberste S, Srikantiah P, Tang P, Couto P, Smith P, Coyle PV, Dussart P, Nguyen PN, Okada PA, Wijesinghe PR, Samuel R, Brown R, Pebody R, Fasce R, Jha R, Lindstrom S, Gerber S, Potdar V, Dong X, Deng YM.   +74 more
europepmc   +1 more source

The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences [PDF]

, 2015
Nicola Normanno, Carmine Pinto, Franca Castiglione, Francesca Fenizia, Massimo Barberis, Antonio Marchetti, Gabriella Fontanini, Gaetano De Rosa, Gian Luigi Taddei   +8 more
openalex   +1 more source

Control material for external quality assessment in haematology

Biochemia medica, 2016
As in other laboratory diagnostic fields, the main goal of external quality assessment (EQA) in haematology is to achieve the lowest possible interlaboratory variation for haematological parameters since those parameters are mainly used for monitoring purposes and the differences between two patient results should not be jeopardized by analytical ...
openaire   +1 more source

Annual 12‐Week Dosing Gap of Natalizumab: Clinical Efficacy, Blood Biomarkers, and CSF Cell Composition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Natalizumab (NTZ) is a highly effective therapy for multiple sclerosis (MS); however, its use is limited by the risk of a rare potentially severe opportunistic brain infection, progressive multifocal leukoencephalopathy (PML). Alternative dosing strategies are evaluated to reduce PML risk while still maintaining efficacy, which ...
Regina Berkovich, Tilman Schneider‐Hohendorf, Eric Baetscher, Evan L. Riddle, Marie Deffner, Emily Katsnelson, Janine Ferrant‐Orgettas, Julie Czerkowicz, John Anderson, Susan E. Goelz, Nicholas Schwab   +10 more
wiley   +1 more source

External Quality Assessment Program for SARS-COV-2 Molecular Detection in Pakistan. [PDF]

Influenza Other Respir Viruses
Badar N, Ikram A, Salman M, Saeed S, Mirza HA, Ahad A, Ashraf A, Farooq U.   +7 more
europepmc   +1 more source

Fifteen years of external quality assessment in leukemia/lymphoma immunophenotyping in The Netherlands and Belgium: A way forward [PDF]

, 2015
Frank Preijers, Vincent H. J. van der Velden, Tim Preijers, Rik A. Brooimans, Erik W.A. Marijt, Christa Homburg, Kees van Montfort, Jan W. Gratama   +7 more
openalex   +1 more source